Personal information

Activities

Collapse all

Works (2)

Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial

Nature Medicine
2023-09 | Journal article
DOI: 10.1038/s41591-023-02498-y
Contributors: Ari VanderWalde; Shay L. Bellasea; Kari L. Kendra; Nikhil I. Khushalani; Katie M. Campbell; Philip O. Scumpia; Lawrence F. Kuklinski; Frances Collichio; Jeffrey A. Sosman; Alexandra Ikeguchi et al.
Source: check_circle
Crossref

Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial

Nature Medicine
2022-11 | Journal article
DOI: 10.1038/s41591-022-02015-7
Contributors: Richard D. Carvajal; Marcus O. Butler; Alexander N. Shoushtari; Jessica C. Hassel; Alexandra Ikeguchi; Leonel Hernandez-Aya; Paul Nathan; Omid Hamid; Josep M. Piulats; Matthew Rioth et al.
Source: check_circle
Crossref
How many people are using ORCID?